Expression of ErbB-1 and ErbB-2 in meningioma

Journal of Clinical Neuroscience

Volumn 17, Issue 9, 2010, Pages 1155-1158

  Wickremesekera, Agadha ^a   Hovens, Christopher M ^b   Kaye, Andrew H ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Benign tumourigenesis; ErbB 2; Meningioma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ACOUSTIC NEURINOMA; ARTICLE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; PERIPHERAL NERVES; PROTEIN MULTIMERIZATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 77955554814     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.02.006     Document Type: Article

References (28)

1. M. Bondy, and B.L. Ligon Epidemiology and etiology of intracranial meningiomas: a review J Neurooncol 29 1996 197 205
2. R.C. Chan, and G.B. Thompson Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases J Neurosurg 60 1984 52 60
3. N.M. Barbaro, P.H. Gutin, and C.B. Wilson Radiation therapy in the treatment of partially resected meningiomas Neurosurgery 20 1987 525 528
4. B.J. Goldsmith, W.M. Wara, and C.B. Wilson Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990 J Neurosurg 80 1994 195 201
5. M.C. Chamberlain Meningiomas Curr Treat Options Neurol 3 2001 67 76
6. A. Wickremesekera, C.M. Hovens, and A.H. Kaye Expression of ErbB-1 and 2 in vestibular schwannomas J Clin Neurosci 14 2007 1199 1206
7. D. Karunagaran, E. Tzahar, and R.R. Beerli ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer EMBO J 15 1996 254 264
8. J. Schlessinger, and A. Ullrich Growth factor signaling by receptor tyrosine kinases Neuron 9 1992 383 391
9. F. Lonardo, E. Di Marco, and C.R. King The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand New Biol 2 1990 992 1003
10. R. Pinkas-Kramarski, M. Shelly, and S. Glathe Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations J Biol Chem 271 1996 19029 19032
11. R. Goldman, R.B. Levy, and E. Peles Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation Biochemistry 29 1990 11024 11028
12. D.J. Riese, T.M. van Raaij, and G.D. Plowman The cellular response to neuregulins is governed by complex interactions of the erbB receptor family Mol Cell Biol 15 1995 5770 5776
13. T. Wada, X.L. Qian, and M.I. Greene Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function Cell 61 1990 1339 1347
14. Y. Kokai, J.N. Myers, and T. Wada Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts Cell 58 1989 287 292
15. M. Alimandi, A. Romano, and M.C. Curia Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas Oncogene 10 1995 1813 1821
16. E. Tzahar, and Y. Yarden The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands Biochim Biophys Acta 1377 1998 M25 37
17. R. Ben-Levy, H.F. Paterson, and C.J. Marshall A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway EMBO J 13 1994 3302 3311
18. L.N. Klapper, N. Vaisman, and E. Hurwitz A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors Oncogene 14 1997 2099 2109
19. B.D. Cohen, P.A. Kiener, and J.M. Green The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells J Biol Chem 271 1996 30897 30903
20. R.A. Shiurba, L.F. Eng, and H. Vogel Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells Cancer 62 1988 2139 2144
21. N.R. Jones, M.L. Rossi, and M. Gregoriou Epidermal growth factor receptor expression in 72 meningiomas Cancer 66 1990 152 155
22. R.S. Carroll, P.M. Black, and J. Zhang Expression and activation of epidermal growth factor receptors in meningiomas J Neurosurg 87 1997 315 323
23. B.S. Chozick, D.L. Benzil, and E.G. Stopa Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas J Neurooncol 27 1996 117 126
24. S.H. Torp, E. Helseth, and G. Unsgaard C-erbB-2/HER-2 protein in human intracranial tumours Eur J Cancer 29A 1993 1604 1606
25. K. Schwechheimer, R.M. Läufle, and W. Schmahl Expression of neu/c-erbB-2 in human brain tumors Hum Pathol 25 1994 772 780
26. J. Schlegel, B. Ullrich, and G. Stumm Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas Acta Neuropathol 86 1993 473 479
27. Y. Shi, W. Huang, and Y. Tan A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue Diagn Mol Pathol 18 2009 11 21
28. C. Desmedt, J. Sperinde, and F. Piette Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISH Diagn Mol Pathol 18 2009 22 29